文献速递心外重症与机械循环支持

血流动力学储备可预测左心室辅助装置植入术后早期右心衰竭

Hemodynamic reserve predicts early right heart failure after LVAD implantation.
PubMed 文献 · J Heart Lung Transplant · 2022-07-16

多中心回顾性分析纳入2011年10月至2020年4月接受连续流左心室辅助装置植入且术前右心导管检查中行硝普钠血管扩张试验的70例患者,27例(39%)发生术后早期右心衰竭。无右心衰竭组硝普钠给药期间峰值每搏量指数更高(30.1 ± 8.8 vs 21.7 ± 7.4 mL/m2,p < 0.001),峰值每搏量指数每降低1 ml/m2早期右心衰竭风险增加16%。

要点

  • 70例连续流左心室辅助装置植入患者中27例(39%)发生早期右心衰竭。
  • 无右心衰竭组硝普钠给药期间峰值每搏量指数高于右心衰竭组。
  • 峰值每搏量指数每降低1 ml/m2,早期右心衰竭风险增加16%。

核心结论

  • 硝普钠给药期间的峰值每搏量指数与左心室辅助装置植入术后早期右心衰竭独立相关,而静息血流动力学则不然。
  • 血管扩张试验可能成为评估左心室辅助装置候选资格时的有力风险分层工具,但尚需额外的前瞻性验证。

研究设计与样本

  • 多中心回顾性分析,纳入2011年10月至2020年4月接受连续流左心室辅助装置植入的患者。
  • 仅纳入术前右心导管检查期间行硝普钠血管扩张试验者(n = 70)。
  • 采用多变量逻辑回归确定以机械循环支持-学术研究联盟标准定义的早期右心衰竭的独立预测因素。
  • 随访队列为2020年7月至2021年10月的10例连续患者。

主要发现

  • 27例患者发生左心室辅助装置植入术后早期右心衰竭(39%)。
  • 有与无右心衰竭患者的基线临床特征相似。
  • 无右心衰竭组硝普钠给药期间峰值每搏量指数为30.1 ± 8.8 mL/m2,右心衰竭组为21.7 ± 7.4 mL/m2(p < 0.001;AUC:0.78;最佳切点:22.1 mL/m2)。
  • 多变量分析显示峰值每搏量指数与早期右心衰竭显著相关,每搏量指数每降低1 ml/m2早期右心衰竭风险增加16%。
  • 2020年7月至2021年10月的10例连续患者随访队列中,所有患者均根据峰值每搏量指数被正确分类为早期右心衰竭或无右心衰竭。

关键数值与推荐

  • 早期右心衰竭定义采用机械循环支持-学术研究联盟标准。
  • 峰值每搏量指数预测早期右心衰竭的AUC为0.78,最佳切点为22.1 mL/m2。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文结论指出尚需额外的前瞻性验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Early right heart failure (RHF) remains a major source of morbidity and mortality after left ventricular assist device (LVAD) implantation, yet efforts to predict early RHF have proven only modestly successful. Pharmacologic unloading of the left ventricle may be a risk stratification approach allowing for assessment of right ventricular and hemodynamic reserve. METHODS: We performed a multicenter, retrospective analysis of patients who had undergone continuous-flow LVAD implantation from October 2011 to April 2020. Only those who underwent vasodilator testing with nitroprusside during their preimplant right heart catheterization were included (n = 70). Multivariable logistic regression was used to determine independent predictors of early RHF as defined by Mechanical Circulatory Support-Academic Research Consortium. RESULTS: Twenty-seven patients experienced post-LVAD early RHF (39%). Baseline clinical characteristics were similar between patients with and without RHF. Patients without RHF, however, achieved higher peak stroke volume index (SVI) (30.1 ± 8.8 vs 21.7 ± 7.4 mL/m2; p < 0.001; AUC: 0.78; optimal cut-point: 22.1 mL/m2) during nitroprusside administration. Multivariable analysis revealed that peak SVI was significantly associated with early RHF, demonstrating a 16% increase in risk of early RHF per 1 ml/m2 decrease in SVI. A follow up cohort of 10 consecutive patients from July 2020 to October 2021 resulted in all patients being categorized appropriately in regards to early RHF versus no RHF according to peak SVI. CONCLUSION: Peak SVI with nitroprusside administration was independently associated with post-LVAD early RHF while resting hemodynamics were not. Vasodilator testing may prove to be a strong risk stratification tool when assessing LVAD candidacy though additional prospective validation is needed.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Read JM, Azih NI, Peters CJ, et al. Hemodynamic reserve predicts early right heart failure after LVAD implantation. J Heart Lung Transplant. 2022. PMID: 35934606. doi:10.1016/j.healun.2022.07.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。